日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Geobacter lovleyi 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP461030GFO
CSB-EP461030GFO
CSB-BP461030GFO
CSB-MP461030GFO
CSB-EP461030GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Ribosomal protein L11 methyltransferase (prmA) CSB-YP461031GFO
CSB-EP461031GFO
CSB-BP461031GFO
CSB-MP461031GFO
CSB-EP461031GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP461032GFO
CSB-EP461032GFO
CSB-BP461032GFO
CSB-MP461032GFO
CSB-EP461032GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Probable transcriptional regulatory protein Glov_1245 (Glov_1245) CSB-YP461033GFO
CSB-EP461033GFO
CSB-BP461033GFO
CSB-MP461033GFO
CSB-EP461033GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Putative nickel-responsive regulator (Glov_2765) CSB-YP461034GFO
CSB-EP461034GFO
CSB-BP461034GFO
CSB-MP461034GFO
CSB-EP461034GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi 50S ribosomal protein L1 (rplA) CSB-YP461035GFO
CSB-EP461035GFO
CSB-BP461035GFO
CSB-MP461035GFO
CSB-EP461035GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi 50S ribosomal protein L16 (rplP) CSB-YP461036GFO
CSB-EP461036GFO
CSB-BP461036GFO
CSB-MP461036GFO
CSB-EP461036GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi 50S ribosomal protein L6 (rplF) CSB-YP461037GFO
CSB-EP461037GFO
CSB-BP461037GFO
CSB-MP461037GFO
CSB-EP461037GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi 50S ribosomal protein L17 (rplQ) CSB-YP461038GFO
CSB-EP461038GFO
CSB-BP461038GFO
CSB-MP461038GFO
CSB-EP461038GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Phosphoglycerate kinase (pgk) CSB-YP461039GFO
CSB-EP461039GFO
CSB-BP461039GFO
CSB-MP461039GFO
CSB-EP461039GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi NADH-quinone oxidoreductase subunit C (nuoC) CSB-YP461040GFO
CSB-EP461040GFO
CSB-BP461040GFO
CSB-MP461040GFO
CSB-EP461040GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP461041GFO
CSB-EP461041GFO
CSB-BP461041GFO
CSB-MP461041GFO
CSB-EP461041GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Ribosome-binding factor A (rbfA) CSB-YP461042GFO
CSB-EP461042GFO
CSB-BP461042GFO
CSB-MP461042GFO
CSB-EP461042GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Biosynthetic arginine decarboxylase (speA), partial CSB-YP461043GFO
CSB-EP461043GFO
CSB-BP461043GFO
CSB-MP461043GFO
CSB-EP461043GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Probable potassium transport system protein kup (kup), partial CSB-YP461044GFO
CSB-EP461044GFO
CSB-BP461044GFO
CSB-MP461044GFO
CSB-EP461044GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter lovleyi Transcriptional repressor NrdR (nrdR) CSB-YP461045GFO
CSB-EP461045GFO
CSB-BP461045GFO
CSB-MP461045GFO
CSB-EP461045GFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Isochromatium buderi High-potential iron-sulfur protein CSB-YP461046INH
CSB-EP461046INH
CSB-BP461046INH
CSB-MP461046INH
CSB-EP461046INH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium limicola Cobalt transport protein CbiM (cbiM), partial CSB-YP461047DSR1
CSB-EP461047DSR1
CSB-BP461047DSR1
CSB-MP461047DSR1
CSB-EP461047DSR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium limicola Histidinol-phosphate aminotransferase (hisC) CSB-YP461048DSR
CSB-EP461048DSR
CSB-BP461048DSR
CSB-MP461048DSR
CSB-EP461048DSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium limicola Phosphopantetheine adenylyltransferase (coaD) CSB-YP461049DSR
CSB-EP461049DSR
CSB-BP461049DSR
CSB-MP461049DSR
CSB-EP461049DSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×